©The Author(s) 2025.
World J Gastrointest Endosc. Nov 16, 2025; 17(11): 110082
Published online Nov 16, 2025. doi: 10.4253/wjge.v17.i11.110082
Published online Nov 16, 2025. doi: 10.4253/wjge.v17.i11.110082
Table 2 Studies evaluating endoscopic mucosal resection in ulcerative colitis
| Ref. | Patients | EMR type | Lesion type | Key outcomes | Comments |
| Hurlstone et al[11], 2007 | 712 | Conventional EMR | Paris 0-II, ALM, LST | 93% en bloc; 2.4% recurrence; no perforations | Validated safety and efficacy in UC |
| Moyer et al[12], 2024 | 16 | Distal cap EMR | Non-lifting dysplasia | 75% complete resection; 0 SAEs; thermal margin ablation used | Ideal for fibrotic/adherent lesions |
| Hosotani et al[2], 2022 | 1 | UEMR | Flat adenoma with fibrosis | Complete R0 resection; no complications | First UEMR case in UC with fibrosis |
| Takabayashi et al[13], 2022 | 1 | UEMR | Lesion over ulcer/tattoo | En bloc resection; negative margins; safe in fibrotic UC | Demonstrates feasibility in scarred mucosa |
- Citation: Pal P, Kata P, Nabi Z, Ramchandani M, Gupta R, Tandan M, Duvvur NR. Endoscopic resection of colitis-associated neoplasia: A scoping review. World J Gastrointest Endosc 2025; 17(11): 110082
- URL: https://www.wjgnet.com/1948-5190/full/v17/i11/110082.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i11.110082